Impact of nicotine withdrawal on novelty reward and related behaviors.

The authors tested the decreased reward function hypothesis of nicotine withdrawal using a novel-object place conditioning task. A conditioned place preference was evident in controls and in rats that had experienced 4 nicotine withdrawal days, but not in rats that had experienced 1-3 withdrawal days. This implies that the rewarding properties of interacting with novel objects were not readily associated with the environment in which they were paired. Follow-up experiments eliminated other explanations based on withdrawal-induced failures to process object or environment information. Also, expression of conditioning was not affected, indicating that withdrawal likely altered acquisition. Further investigation into the neurochemical and behavioral changes that accompany nicotine withdrawal will lead to a better understanding of the withdrawal syndrome.

[1]  Michael T. Bardo,et al.  Conditioned increase in place preference by access to novel objects: antagonism by MK-801 , 1999, Behavioural Brain Research.

[2]  J. Stephenson,et al.  Chronic treatments with cholinoceptor drugs influence spatial learning in rats , 2005, Psychopharmacology.

[3]  M. Tsuda,et al.  Mecamylamine-precipitated nicotine-withdrawal aversion in rats. , 1996, European journal of pharmacology.

[4]  R. Bevins,et al.  Nicotine enhances acquisition of a T‐maze visual discrimination: assessment of individual differences , 2000, Behavioural Pharmacology.

[5]  R. Bevins,et al.  Novel-object place conditioning: behavioral and dopaminergic processes in expression of novelty reward , 2002, Behavioural Brain Research.

[6]  T. Svensson,et al.  Selective c‐fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine‐precipitated nicotine withdrawal syndrome , 2000, Synapse.

[7]  Alice B. Sheldon.  Preference for familiar versus novel stimuli as a function of the familiarity of the environment. , 1969 .

[8]  T. Svensson,et al.  Behavioral and Biochemical Manifestations of Mecamylamine-Precipitated Nicotine Withdrawal in the Rat: Role of Nicotinic Receptors in the Ventral Tegmental Area , 1999, Neuropsychopharmacology.

[9]  S. Cooper,et al.  The Neuropharmacological basis of reward , 1989 .

[10]  K. Rasmussen,et al.  Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity , 2005, Psychopharmacology.

[11]  G. Koob,et al.  Dramatic decreases in brain reward function during nicotine withdrawal , 1998, Nature.

[12]  R. Kuolee,et al.  Effect of chronic nicotine on brain stimulation reward. II. An escalating dose regimen , 1998, Behavioural Brain Research.

[13]  Stephen P. Fortmann,et al.  Prospective study of factors influencing the development of craving associated with smoking cessation , 2005, Psychopharmacology.

[14]  R. Bevins,et al.  Environmental Familiarization in Rats: Differential Effects of Acute and Chronic Nicotine , 2001, Neurobiology of Learning and Memory.

[15]  E. Levin,et al.  Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. , 1990, Behavioral and neural biology.

[16]  S. File,et al.  Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. , 1999, Behavioural pharmacology.

[17]  R. Bevins,et al.  Dopaminergic and cholinergic antagonism in a novel-object detection task with rats , 2001, Behavioural Brain Research.

[18]  T. Shippenberg,et al.  Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. , 1988, European journal of pharmacology.

[19]  Ian P. Stolerman,et al.  Nicotine enhances sustained attention in the rat under specific task conditions , 1998, Psychopharmacology.

[20]  R. Bevins,et al.  The role of environmental familiarization in novel-object preference , 2000, Behavioural Processes.

[21]  B. Martin,et al.  What is the nature of mecamylamine's antagonism of the central effects of nicotine? , 1989, Biochemical pharmacology.

[22]  J. Lake,et al.  Rodent model of nicotine abstinence syndrome , 1992, Pharmacology Biochemistry and Behavior.

[23]  R. West,et al.  Randomised controlled trial of ondansetron in smoking cessation , 1996, Psychopharmacology.

[24]  K. Kellar,et al.  Chronic nicotine and locomotor activity: influences of exposure dose and test dose , 2004, Psychopharmacology.

[25]  T. Svensson,et al.  Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome , 1998, Brain Research.

[26]  Rick A Bevins,et al.  Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats , 1999, Behavioural Brain Research.

[27]  G. Koob,et al.  Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. , 2000, The Journal of pharmacology and experimental therapeutics.

[28]  G. Di Chiara,et al.  Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. , 2000, Drug and alcohol dependence.

[29]  P. Clarke,et al.  The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats , 1983, British journal of pharmacology.

[30]  R. Bevins,et al.  Conditioned place preference: what does it add to our preclinical understanding of drug reward? , 2000, Psychopharmacology.

[31]  S. Shiffman,et al.  The effect of bupropion on nicotine craving and withdrawal , 2000, Psychopharmacology.

[32]  R. Bevins,et al.  Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression , 2001, Pharmacology Biochemistry and Behavior.

[33]  A. J. Connor.  Cigarette smoking among adults--United States, 1999. , 2001, MMWR. Morbidity and mortality weekly report.

[34]  Cigarette smoking among adults--United States, 1993. , 1994, MMWR. Morbidity and mortality weekly report.

[35]  J. Lake,et al.  The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat , 1994, Psychopharmacology.

[36]  D. Berlyne.  NOVELTY AND CURIOSITY AS DETERMINANTS OF EXPLORATORY BEHAVIOUR1 , 1950 .

[37]  T. Cicero,et al.  Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the rat. , 1974, Neuropharmacology.

[38]  L. Cervo,et al.  Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference , 1995, Brain Research.

[39]  M. Misawa,et al.  Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains. , 1999, European Journal of Pharmacology.

[40]  G. Koob,et al.  Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal , 1990, Neuroscience.

[41]  R. Bevins.  Novelty Seeking and Reward: Implications for the Study of High-Risk Behaviors , 2001 .

[42]  T. Cicero,et al.  Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal. , 1998, European journal of pharmacology.

[43]  T. Tzschentke,et al.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues , 1998, Progress in Neurobiology.

[44]  A. Phillips,et al.  Conditioned place preference as a measure of drug reward. , 1989 .

[45]  J R Hughes,et al.  Symptoms of tobacco withdrawal. A replication and extension. , 1991, Archives of general psychiatry.

[46]  A. Harrison,et al.  Fluoxetine Combined with a Serotonin-1A Receptor Antagonist Reversed Reward Deficits Observed during Nicotine and Amphetamine Withdrawal in Rats , 2001, Neuropsychopharmacology.

[47]  M. Schmid,et al.  Effects of nicotine withdrawal on central dopaminergic systems , 1996, Pharmacology Biochemistry and Behavior.

[48]  R. Beninger,et al.  Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors , 1999, Psychopharmacology.

[49]  D. Hatsukami,et al.  Effect of nicotine on the tobacco withdrawal syndrome , 1984, Psychopharmacology.